Transplanting insulin-producing cells along with engineered blood ... “This work lays the foundation for subcutaneous [under the skin] islet transplants as a relatively safe and durable ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine ...

A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic ...

POSTECH researchers develop 3D printed platform to enhance diabetes treatment POSTECH scientists create advanced 3D printing ...

Diabetes is a metabolic disorder caused by dysfunction in the pancreas, the organ responsible for regulating blood sugar levels. Within the pancreas, islet cells secrete insulin to lower blood sugar.

Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a genetically modified pig kidney into a human conducted at Massachusetts General Hospital Announced positi ...

Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its ...

Islet cells regulate insulin secretion through ... and improving the efficiency of islet transplantation therapies." This work was supported by the National Research Foundation of South Korea ...

Researchers have found that some cells form new multicellular structures with functions that defy their original biological ...